What is Abbvie Inc Quarterly Revenue?

Abbvie Inc Quarterly Revenue AbbVie Jun-2026 Quarterly Revenue is $16,990 Million which is growth of 10.2% YoY.

What is Abbvie Inc Quarterly Net Profit?

Abbvie Inc Quarterly Net Profit AbbVie Jun-2026 Quarterly Net Profit is $3,613 Million which is growth of 285.2% YoY.

What is Abbvie Inc Annual Revenue?

Abbvie Inc Annual Revenue AbbVie Dec-2025 Annual Revenue is $61,160 Million which is growth of 8.6% YoY.

What is Abbvie Inc Annual Net Profit?

Abbvie Inc Annual Net Profit AbbVie Dec-2025 Annual Net Profit is $4,226 Million which is growth of -1.2% YoY.

What is Abbvie Inc Total Shareholders Fund?

Abbvie Inc Total Shareholders Fund AbbVie Dec-2025 Total Shareholders Fund is $-3,270 Million which is growth of -198.3% YoY.

What is Abbvie Inc Total Assets?

Abbvie Inc Total Assets AbbVie Dec-2025 Total Assets is $133,960 Million which is growth of -0.9% YoY.

What is Abbvie Inc Book Value Per Share?

Abbvie Inc Book Value Per Share AbbVie Book Value Per Share is $-2 which is growth of -198.2% YoY.

What is Abbvie Inc ROE?

Abbvie Inc ROE AbbVie ROE is 0% which is growth of 0% YoY.

What is Abbvie Inc Cash From Operating Activity?

Abbvie Inc Cash From Operating Activity AbbVie Dec-2025 Cash From Operating Activity is $19,030 Million which is growth of 1.2% YoY.

What is Abbvie Inc Net Cash Flow?

Abbvie Inc Net Cash Flow AbbVie Dec-2025 Net Cash Flow is $-337 Million which is growth of 95.3% YoY.

Abbvie Inc

XNYS: ABBV

Download real time

-6.76(-2.40%)

New 52W High today

6.4M

XNYS Volume

XNYS 13 Oct, 2026 5:30 PM (EDT)

Portfolio

Alert

My Notes

Dividend

AbbVie has an upcoming dividend of $1.730 per share due on 15 Oct 2026See details

AbbVie quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Forecaster Analyst Estimates for AbbVie share price target, revenues, EPS, net income and more

AbbVie quarterly results: revenue, profit, and P&L – 13 quarter history

Nested row level

Base Level

Reporting Type

Originally Reported

Cell Data

Actual

Table Settings

YoY & New to Old

Nested row level

Base Level

Export

POSITIVE
Quarterly Revenue AbbVie Jun-2026 Quarterly Revenue is $16,990 Million which is growth of 10.2% YoY.
POSITIVE
Quarterly Net Profit AbbVie Jun-2026 Quarterly Net Profit is $3,613 Million which is growth of 285.2% YoY.

Abbvie Inc, Earnings Report - Quarterly Results, standalone, All financials are in USD Million and price data in USD
Indicator	Jun '26	Mar '26	Dec '25	Sep '25	Jun '25	Mar '25	Dec '24	Sep '24	Jun '24	Mar '24	Dec '23	Sep '23	Jun '23
SR_Q Operating Rev.	16,990	15,002	16,618	15,776	15,423	13,343	15,102	14,460	14,462	12,310	14,301	13,927	13,865
CostOfRevenue_Q Cost Of Rev.	4,291	4,218	4,552	5,304	4,346	4,002	4,396	4,212	4,202	4,094	5,704	6,485	4,240
GrossProfit_Q Gross Profit	12,699	10,784	12,066	10,472	11,077	9,341	10,706	10,248	10,260	8,216	8,597	7,442	9,625
OEXPNS_Q Operating Exp. ⌄	5,976	6,050	6,257	5,888	5,360	5,360	10,622	6,335	5,325	5,254	5,402	5,161	5,112
AdminAndSellingExpenses_Q Admin Plus Selling Exp.	3,632	3,578	3,895	3,569	3,253	3,293	3,855	4,205	3,377	3,315	3,193	3,372	3,268
ResearchAndDevlopmentExpenses_Q RnD Exp.	2,344	2,472	2,579	2,319	2,131	2,067	6,774	2,130	1,948	1,939	2,209	1,789	2,013
OP_Q Operating Profit	6,723	4,734	5,809	4,584	5,717	3,981	84	3,913	4,935	2,962	3,195	2,281	4,513
NetNonOperIntIncExp_Q Net Non Operations Interest Incuding Expenses ⌄	-679	-645	-655	-667	-678	-627	-610	-591	-506	-453	-378	-398	-454
Others_Q Other Interest Earned	67	72	59	72	62	73	92	129	220	207	186	157	98
IntExpNonOperating_Q Interest Exp. Non Operating	746	717	714	739	740	700	702	720	726	660	564	555	552
PBT_Q Profit Before Tax	4,278	1,039	2,668	714	1,554	1,661	-2,269	2,084	2,146	1,755	1,212	1,953	2,610
TAX_Q Tax	662	342	853	526	613	372	-2,246	520	773	383	388	172	583
NICommonStockholders_Q Net Income Common Stockholders ⌄	3,601	685	1,806	176	928	1,276	-32	1,551	1,360	1,359	779	1,778	2,013
NP_Q Net Profit	3,613	695	1,816	186	938	1,286	-22	1,561	1,370	1,369	822	1,778	2,024
NIIncludingNoncontrollingInterests_Q Net Income Including Non controlling Interests	3,616	697	1,815	188	941	1,289	-23	1,564	1,373	1,372	824	1,781	2,027
DilutedNIAvailtoComStockholders_Q Diluted NI Avail to Com Stockholders Ann.	3,601	685	1,806	176	928	1,276	-32	1,551	1,360	1,359	779	1,778	2,013
EPS_Q Basic EPS	2	0.4	1	0.1	0.5	0.7	-0	0.9	0.8	0.8	0.5	1	1.1
AfterDilutedEPS_Q Diluted EPS After ExtraOrdinary	3.7	2.7	2.7	1.9	3	2.5	2.2	3	2.7	2.3	2.8	3	2.9
SHARE_Q Number Of Shares End	1,769	1,770	1,769	1,769	1,768	1,768	1,769	1,769	1,768	1,769	1,768	1,767	1,767
NIContinuingDiscontinuedOper_Q Net Income Continuing Discontinued Operations	3,613	695	1,816	186	938	1,286	-22	1,561	1,370	1,369	822	1,778	2,024
NormalizedIncome_Q Normalized Income	6,491	4,711	4,830	3,306	5,278	4,370	3,844	5,327	4,710	4,120	4,959	5,250	5,175
InterestIncome_Q Interest Income	67	72	59	72	62	73	92	129	220	207	186	157	98
INT_Q Interest	746	717	714	739	740	700	702	720	726	660	564	555	552
NetInterestIncome_Q Net Interest Income	-679	-645	-655	-667	-678	-627	-610	-591	-506	-453	-378	-398	-454
EBIT_Q EBIT	4,957	1,684	3,323	1,381	2,232	2,288	-1,659	2,675	2,652	2,208	1,590	2,351	3,064
EBITDA_Q EBITDA	6,840	3,620	5,310	3,473	4,282	4,369	443	4,766	4,736	4,282	3,666	4,547	5,354
ReconciledCostOfRevenue_Q Reconciled Cost Of Rev.	4,291	4,218	4,552	5,304	4,346	4,002	4,396	4,212	4,202	4,094	5,704	6,485	4,240
ReconciledDepreciation_Q Reconciled Depr.	1,883	1,936	1,987	2,063	2,050	2,039	2,102	2,079	2,131	2,074	2,076	2,235	2,260
ProfitLossFromContinuingOperations_Q Profit From Continuing Operations	3,616	697	1,815	188	941	1,289	-23	1,564	1,373	1,372	824	1,781	2,027
NormalizedEBITDA_Q Normalized EBITDA	7,198	4,436	6,645	6,216	5,190	4,652	2,128	4,962	5,941	4,657	3,901	4,768	5,459

*All financials are in USD Million and price data in USD

Add metric to table

Search...

AbbVie competitor comparison and performance snapshot within industry

AbbVie annual results: revenue, profit, P&L, and margins as of Dec 2025 – 11 year history

Nested row level

Base Level

Reporting Type

Originally Reported

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Annual Revenue AbbVie Dec-2025 Annual Revenue is $61,160 Million which is growth of 8.6% YoY.
NEGATIVE
Annual Net Profit AbbVie Dec-2025 Annual Net Profit is $4,226 Million which is growth of -1.2% YoY.

Abbvie Inc, Earnings Report - Annual Results, standalone, All financials are in USD Million and price data in USD
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	TTM	Dec '25	Dec '24	Dec '23	Dec '22	Dec '21	Dec '20	Dec '19	Dec '18	Dec '17	Dec '16	Dec '15
SR_A Total Rev. Ann. ⌄	1.8%	6%		61,160	56,334	54,318	58,054	56,197	45,804	33,266	32,753	28,216	25,638	22,859
TotalOperatingRevenues_A Operating Rev. Ann.	1.8%	6%	64,386	61,160	56,334	54,318	58,054	56,197	45,804	33,266	32,753	28,216	25,638	22,859
CostOfRevenue_A Cost Of Rev. Ann.	1.5%	3.4%	18,365	18,204	16,904	20,415	17,414	17,446	15,387	7,439	7,718	7,040	5,833	4,500
GrossProfit_A Gross Profit Ann.	1.9%	7.1%	46,021	42,956	39,430	33,903	40,640	38,751	30,417	25,827	25,035	21,176	19,805	18,359
OEXPNS_A Operating Exp. Ann.	0.5%	3.7%	24,171	22,865	27,536	21,146	22,523	20,827	19,054	12,844	18,652	11,584	10,421	10,822
OP_A Operating Profit Ann.	3.5%	12.1%	21,850	20,091	11,894	12,757	18,117	17,924	11,363	12,983	6,383	9,592	9,384	7,537
NetNonOperIntIncExp_A Net Non Operations Interest Incuding Expenses Ann, ⌄	-	-	-2,646	-2,627	-2,160	-1,684	-2,044	-2,384	-2,280	-1,509	-1,144	-1,004	-965	-686
Others_A Other Interest Earned Ann.	12.7%	8.9%	270	266	648	540	186	39	174	275	204	146	82	33
IntExpNonOperating_A Interest Exp. Non Operating Ann.	9.1%	3.3%	2,916	2,893	2,808	2,224	2,230	2,423	2,454	1,784	1,348	1,150	1,047	719
OtherExpenses_A Other Exp. Ann.	-	-		-10,867	-6,018	-4,823	-2,596	-2,551	-5,685	-3,048	-42	-861	-535	-206
PBT_A PBT Ann.	-21.2%	14.2%	8,699	6,597	3,716	6,250	13,477	12,989	3,398	8,426	5,197	7,727	7,884	6,645
TAX_A Tax Ann.	13.1%	-	2,383	2,364	-570	1,377	1,632	1,440	-1,224	544	-490	2,418	1,931	1,501
NICommonStockholders_A Net Income Common Stockholders Ann. ⌄	-29.2%	-1.7%	6,268	4,186	4,238	4,820	11,782	11,468	4,556	7,842	5,657	5,283	5,923	5,144
NP_A Net Profit Ann.	-29.1%	-1.7%	6,310	4,226	4,278	4,863	11,836	11,542	4,616	7,882	5,687	5,309	5,953	5,144
NIIncludingNoncontrollingInterests_A Net Income Including Non controlling Interests Ann.	-29%	-1.7%	6,316	4,233	4,286	4,873	11,845	11,549	4,622	7,882	5,687	5,309	5,953	5,144
DilutedNIAvailtoComStockholders_A Diluted NI Avail to Com Stockholders Ann.	-29.2%	-1.7%	6,268	4,186	4,238	4,820	11,782	11,468	4,556	7,842	5,657	5,283	5,923	5,144
EPS_A EPS Ann.	-29%	-2.3%		2.4	2.4	2.7	6.7	6.5	2.7	5.3	3.7	3.3	3.7	3.2
DilutedEPS_A Diluted EPS Ann.	-28.6%	-2.3%		2.4	2.4	2.7	6.6	6.5	2.7	5.3	3.7	3.3	3.6	3.1
SHARE_Q Number Of Shares End	0%	0%		1,769	1,769	1,768	1,771	1,773	1,769	1,484	1,496	1,596	1,616	1,631
TotalExpenses_A Total Exp. Ann.	0.9%	3.6%		41,069	44,440	41,561	39,937	38,273	34,441	20,283	26,370	18,624	16,254	15,322
NIContinuingDiscontinuedOper_A Net Income Continuing Discontinued Operations Ann.	-29.1%	-1.7%	6,310	4,226	4,278	4,863	11,836	11,542	4,616	7,882	5,687	5,309	5,953	5,144
NormalizedIncome_A Normalized Income Ann.	-10.2%	0%	19,338	17,784	18,001	19,769	24,597	22,696	17,781	13,324	12,282	9,011	7,904	7,060
InterestIncome_A Interest Income Ann.	12.7%	8.9%	270	266	648	540	186	39	174	275	204	146	82	33
INT_A Interest Ann.	9.1%	3.3%	2,916	2,893	2,808	2,224	2,230	2,423	2,454	1,784	1,348	1,150	1,047	719
EBITDA_A EBITDA Ann.	-10.2%	7.4%	19,243	17,363	14,262	16,632	23,988	23,894	12,149	11,952	8,106	10,232	10,038	8,167
ReconciledCostOfRevenue_A Reconciled Cost Of Rev. Ann.	1.5%	3.4%	18,365	18,204	16,904	20,415	17,414	17,446	15,387	7,439	7,718	7,040	5,833	4,500
ReconciledDepreciation_A Reconciled Depr. Ann.	-1.3%	4.7%	7,869	8,139	8,386	8,698	8,467	8,521	6,471	2,017	1,765	1,501	1,189	836
ProfitLossFromContinuingOperations_A Profit From Continuing Operations Ann.	-29%	-1.7%	6,316	4,233	4,286	4,873	11,845	11,549	4,622	7,882	5,687	5,309	5,953	5,144
NormalizedEBITDA_A Normalized EBITDA Ann.	-2.3%	12.9%	24,495	22,703	17,688	17,318	24,322	23,984	12,394	12,269	8,334	10,726	10,423	8,393

*All financials are in USD Million and price data in USD

Add metric to table

Search...

Total Rev. Ann.

1Y CHG

8.6%

2Y CAGR

6.1%

3Y CAGR

1.8%

5Y CAGR

7Y CAGR

9.3%

10Y CAGR

10.3%

Total Revenue Annual growth is stable compared to historical averages.

Net Profit Ann.

1Y CHG

-1.2%

2Y CAGR

-6.8%

3Y CAGR

-29.1%

5Y CAGR

-1.7%

7Y CAGR

-4.2%

10Y CAGR

-1.9%

Net Profit Annual is falling slower than historical averages.

Operating Exp. Ann.

1Y CHG

-17%

2Y CAGR

3Y CAGR

0.5%

5Y CAGR

3.7%

7Y CAGR

10Y CAGR

7.8%

Operating Expenses Annual Cr is falling faster than historical averages.

AbbVie balance sheet as of Dec 2025: assets, liabilities, reserves, and borrowings – 11 year history

Nested row level

Base Level

Reporting Type

Originally Reported

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

NEGATIVE
Total Shareholders Fund AbbVie Dec-2025 Total Shareholders Fund is $-3,270 Million which is growth of -198.3% YoY.
NEGATIVE
Total Assets AbbVie Dec-2025 Total Assets is $133,960 Million which is growth of -0.9% YoY.

Abbvie Inc, Balance Sheet, standalone, All financials are in USD Million and price data in USD
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Dec '25	Dec '24	Dec '23	Dec '22	Dec '21	Dec '20	Dec '19	Dec '18	Dec '17	Dec '16	Dec '15
TA_A Total Assets Ann. ⌄	-1.2%	-2.3%	133,960	135,161	134,711	138,805	146,529	150,565	89,115	59,352	70,786	66,099	53,050
CA_A Total Current Assets Ann.	0.7%	3.8%	29,062	25,582	33,002	28,463	27,928	24,173	49,519	16,945	21,223	16,187	16,314
CashEquivalentsShortTermInvestments_A Cash Equivalents and Short Term Investments Ann.	-17.1%	-9.1%	5,257	5,555	12,816	9,229	9,830	8,479	39,924	8,061	9,789	6,423	8,407
Receivables_A Change In Account Receivables Ann.	3.8%	7.4%	12,589	10,919	11,155	11,254	9,977	8,822	5,428	5,384	5,088	4,758	4,730
Inventories_A Inventories Ann.	11.4%	8.4%	4,951	4,181	4,099	3,579	3,128	3,310	1,813	1,605	1,605	1,444	1,719
OtherCurrentAssets_A Other Current Assets Ann.	12.5%	-	6,265	4,927	4,932	4,401	-	-	-	-	-	-	-
TotalNonCurrentAssets_A Total Non Current Assets Ann.	-1.7%	-3.7%	104,898	109,579	101,709	110,342	118,601	126,392	39,596	42,407	49,563	49,912	36,736
NetPPE_A Net PPE Ann.	4.5%	1.4%	5,628	5,134	4,989	4,935	5,110	5,248	2,962	2,883	2,803	2,604	2,565
InvestmentsAndAdvances_A Investments & Advances Ann.	3.6%	-1.8%	268	279	304	241	277	293	93	1,420	2,090	1,783	145
OtherNonCurrentAssets_A Other Non Current Assets Ann.	24.4%	17.2%	10,721	9,142	8,513	5,571	4,884	4,851	2,288	1,208	1,326	1,212	1,149
TotalLiabilitiesNetMinorityInterest_A Total Liabilities Net Minority Interest Ann. ⌄	4.1%	0%	137,188	131,797	124,314	121,518	131,093	137,468	97,287	67,798	65,689	61,463	49,105
CL_A Total Current Liabilities Ann.	13.6%	8.6%	43,289	38,749	37,841	29,538	35,194	28,661	15,585	17,239	16,641	9,781	10,894
PayablesAndAccruedExpenses_A Payables & Accrued Exp.s Ann.	11%	11.5%	34,734	31,945	30,650	25,402	22,699	20,159	11,832	11,931	10,226	9,379	8,463
CurrentDebtCapLeaseObligation_A Current Debt Cap Lease Obligation Ann.	27.4%	0.1%	8,555	6,804	7,191	4,136	12,495	8,502	3,753	5,308	6,415	402	2,431
CurrentDeferredLiabilities_Q Current Deferred Liabilities	-	-	-	14,304	13,627	10,717	8,254	7,188	4,484	3,939	3,069	2,887	2,355
OtherCurrentLiabilities_A Other Current Liabilities Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
TotalNonCurrentLiabilities_A Total Non Current Liabilities Ann.	0.7%	-2.9%	93,899	93,048	86,473	91,980	95,899	108,807	81,702	50,559	49,048	51,682	38,211
LongTermDebtAndCapitalLeaseObligation_Q LT Debt & Capital Lease Obligation	-0.1%	-5.3%	58,941	60,340	52,194	59,135	64,189	77,554	62,975	35,002	30,953	36,440	29,240
TradeandOtherPayablesNonCurrent_A Trade & Other Payables Non Current Ann.	-50.4%	-37.6%	364	1,261	2,182	2,985	3,442	3,847	3,453	4,311	4,675	-	-
TotalDeferredCreditsAndOtherNonCurrentLiabilities_A Total Deferred Credits & Other Non Current Liabilities Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
TotalShareHoldersFunds_A Total ShareHolders Funds Ann. ⌄	-	-	-3,270	3,325	10,360	17,254	15,408	13,076	-8,172	-8,446	5,097	4,636	3,945
EQCAP_A Equity Share Capital Ann.	-	-	-3,270	3,325	10,360	17,254	15,408	13,076	-8,172	-8,446	5,097	4,636	3,945
CapitalStock_A Capital Stock Ann.	0%	0%	18	18	18	18	18	18	18	18	18	18	17
RetainedEarnings_A Retained Earnings Ann.	-	-	-15,493	-7,900	-1,000	4,784	3,127	1,055	4,717	3,368	5,459	4,378	2,248
GainsLossesNotAffectingRetainedEarnings_A Gains Losses Not Affecting Retained Earnings Ann.	-	-	-1,144	-1,925	-2,305	-2,199	-2,899	-3,117	-3,596	-2,480	-2,727	-2,586	-2,561
TotalCapitalization_A Total Capitalization Ann.	-10%	-9.3%	55,671	63,665	62,554	76,389	79,597	90,630	54,803	26,556	36,050	41,076	33,185
TangibleAssets_A Tangible Assets Ann.	-	-	-91,551	-91,699	-77,543	-82,341	-92,922	-102,924	-42,425	-45,342	-38,247	-39,677	-28,932
WC_A Working Capital Ann.	-	-	-14,227	-13,167	-4,839	-1,075	-7,266	-4,488	33,934	-294	4,582	6,406	5,420
InvestedCapital_A Invested Capital Ann.	-7.3%	-8.3%	64,226	70,469	69,745	80,525	92,092	99,132	58,556	31,864	42,465	41,478	35,616
TangibleBookValue_A Tangible Book Value Ann.	-	-	-91,551	-91,699	-77,543	-82,341	-92,922	-102,924	-42,425	-45,342	-38,247	-39,677	-28,932
Borrowings_A Borrowings Ann.	2.2%	-4.7%	67,496	67,144	59,385	63,271	76,684	86,056	66,728	40,310	37,368	36,842	31,671
NetDebt_A Net Debt Ann.	4.8%	-4.3%	62,267	61,620	46,571	54,070	66,938	77,607	26,804	33,021	28,065	31,742	23,272
ShareIssued_A Share Issued Ann.	0.5%	0.5%	1,838.7	1,831.6	1,823.1	1,813.8	1,803.2	1,792.1	1,781.6	1,776.5	1,768.7	1,754.9	1,749
SHARE_Q Number Of Shares End	0%	0%	1,769	1,769	1,768	1,771	1,773	1,769	1,484	1,496	1,596	1,616	1,631

*All financials are in USD Million and price data in USD

Add metric to table

Search...

Total Assets Ann.

1Y CHG

-0.9%

2Y CAGR

-0.3%

3Y CAGR

-1.2%

5Y CAGR

-2.3%

7Y CAGR

12.3%

10Y CAGR

9.7%

Total Assets Annual is falling faster than historical averages.

Total Current Liabilities Ann.

1Y CHG

11.7%

2Y CAGR

3Y CAGR

13.6%

5Y CAGR

8.6%

7Y CAGR

14.1%

10Y CAGR

14.8%

Total Current Liabilities Annual Cr growth is stable compared to historical averages.

AbbVie ROE, ROCE, book value, and debt-to-equity ratio as of Dec 2025 – 11 year history

Nested row level

Base Level

Reporting Type

Originally Reported

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

NEGATIVE
Book Value Per Share AbbVie Book Value Per Share is $-2 which is growth of -198.2% YoY.
NEUTRAL
ROE AbbVie ROE is 0% which is growth of 0% YoY.

Abbvie Inc, Ratios, standalone, All financials are in USD Million and price data in USD
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Dec '25	Dec '24	Dec '23	Dec '22	Dec '21	Dec '20	Dec '19	Dec '18	Dec '17	Dec '16	Dec '15
ROA_A RoA Ann. %	-	-	-	3.14%	3.52%	8.26%	7.72%	3.80%	10.56%	8.69%	7.72%	9.94%	12.76%
ROE_A ROE Ann. %	-	-	-	61.94%	34.91%	72.14%	80.52%	185.81%	-	-	108.56%	138.05%	180.90%
ROIC_Q ROIC %	-	-	-	0.6	1.5	3.4	4.9	0.5	-	-	0.5	3.7	4.6
OPMPCT_A OPM Ann. %	1.7%	5.8%	32.85%	21.11%	23.49%	31.21%	31.89%	24.81%	39.03%	19.49%	33.99%	36.60%	32.97%
NBTO_A Inventory Turnover Ratio Ann.	-	-	-	4.1	5.3	5.2	5.4	6	4.4	4.8	4.6	3.7	3.2
ASETTO_A Asset Turnover Ann. %	-	-	-	0.4	0.4	0.4	0.4	0.4	0.5	0.5	0.4	0.4	0.6
WCTO_A Working Capital Turnover Ann.	-	-	-4.3	-4.3	-11.2	-54	-7.7	-10.2	1	-111.4	6.2	4	4.2
QuickRatio_A Quick Ratio Ann.	-	-	-	0.4	0.6	0.7	0.6	0.6	2.9	0.8	0.9	1.1	1.2
CRATIO_A Current Ratio Ann.	-	-	-	0.7	0.9	1	0.8	0.8	3.2	1	1.3	1.7	1.5
IC_A Interest Coverage Ratio Ann.	-	-	-	2.3	3.8	7	6.4	2.4	5.7	4.9	7.7	8.5	10.2
LTDE_A LT Debt To Equity Ann.	-	-	-	18.2	5	3.4	4.2	5.9	-	-	6.1	7.9	7.4

*All financials are in USD Million and price data in USD

Add metric to table

Search...

AbbVie cash flow: net, operating, investing, and financing flows as of Dec 2025 – 11 year history

Nested row level

Base Level

Reporting Type

Originally Reported

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Cash From Operating Activity AbbVie Dec-2025 Cash From Operating Activity is $19,030 Million which is growth of 1.2% YoY.
POSITIVE
Net Cash Flow AbbVie Dec-2025 Net Cash Flow is $-337 Million which is growth of 95.3% YoY.

Abbvie Inc, Cash Flow, standalone, All financials are in USD Million and price data in USD
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Dec '25	Dec '24	Dec '23	Dec '22	Dec '21	Dec '20	Dec '19	Dec '18	Dec '17	Dec '16	Dec '15
CFO_A Cash from Operating Act. Ann. ⌄	-8.6%	1.6%	19,030	18,806	22,839	24,943	22,777	17,588	13,324	13,427	9,960	7,041	7,535
ProfitLossFromContinuingOperations_A Profit From Continuing Operations Ann.	-29%	-1.7%	4,233	4,286	4,873	11,845	11,549	4,622	7,882	5,687	5,309	5,953	5,144
DepreciationAmortizationDepletion_A Depreciation Amortization Depletion Ann.	-1.3%	4.7%	8,139	8,386	8,698	8,467	8,521	6,471	2,017	1,765	1,501	1,189	836
DepreciationAndAmortization_A Depreciation And Amortization Ann.	-1.3%	4.7%	8,139	8,386	8,698	8,467	8,521	6,471	2,017	1,765	1,501	1,189	836
DeferredTax_A Deferred Tax Ann.	-	-	-492	-1,449	-2,889	-1,931	-898	-2,325		424	1,242	-	-
DeferredIncomeTax_A Deferred Income Tax Ann.	-	-	-492	-1,449	-2,889	-1,931	-898	-2,325		424	1,242	-	-
EmployeesStockOptions_A ESOPs Ann.	12.5%	4.9%	955	911	747	671	692	753	430	421	365	353	282
OtherNonCashItems_A Other Non Cash Items Ann.	37.7%	1.7%	8,643	4,470	4,811	3,308	4,303	7,961	3,624	1,186	1,180	937	769
ChangeInWorkingCapital_A Change In Working Capital Ann.	-	-	-2,362	-2,782	2,813	-258	-1,322	106	-1,329	-1,126	9	-1,689	504
ChangeInReceivables_A Change In Receivables Ann.	-	-	-1,490	207	66	-1,455	-1,321	-929	-74	-591	-391	-71	-1,076
ChangeInInventory_A Change In Inventory Ann.	-	-	-234	-319	-417	-686	-142	-40	-231	-226	93	-38	-434
ChangePayablesAccruedExpense_A Change Payables Accrued Expense Ann.	-16%	-8.9%	951	177	3,840	1,605	1,628	1,514	-1,121	190	425	-1,187	1,503
ChangeInOtherCurrentAssets_A Change In Other Current Assets Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
ChangeInOtherCurrentLiabilities_A Change In Other Current Liabilities Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
ChangeInOtherWorkingCapital_A Change In Other Working Capital Ann.	-	-	-762	-3,208	-488	542	-1,290	-573	-	-	-	-	-
CFI_A Cash from Investing Act. Ann. ⌄	-	-	-6,643	-20,820	-2,009	-623	-2,344	-37,557	596	-1,006	-274	-6,074	-12,936
NetPPEPurchaseAndSale_A Net PPE Purchase & Sale Ann.	-	-	-1,214	-974	-777	-695	-787	-798	-552	-638	-529	-479	-532
PurchaseOfPPE_A Purchase Of PPE Ann.	-	-	-1,214	-974	-777	-695	-787	-798	-552	-638	-529	-479	-532
NetBusinessPurchaseAndSale_A Net Business Purchase & Sale Ann.	-	-	-5,441	-20,517	-1,223	-794	-1,902	-39,610	-1,135	-736	-308	-2,757	-12,452
PurchaseOfBusiness_A Purchase Of Business Ann.	-	-	-5,441	-20,517	-1,223	-794	-1,902	-39,610	-1,135	-736	-308	-2,757	-12,452
PurchaseOfInvestment_A Purchase Of Investment Ann.	-	-	-35	-73	-77	-1,438	-119	-61	-583	-1,792	-2,230	-5,315	-851
SaleOfInvestment_A Sale Of Investment Ann.	-63.2%	-45.1%	76	555	55	1,530	98	1,525	2,699	2,160	2,793	2,359	880
NetOtherInvestingChanges_A Net Other Investing Changes Ann.	-	-	-29	189	13	774	366	1,387	167	-	-	118	19
CFA_A Cash from Financing Act. Ann. ⌄	-	-	-12,724	-5,211	-17,222	-24,803	-19,039	-11,501	18,708	-14,396	-5,512	-3,928	5,752
NetIssuancePaymentsOfDebt_A Net Issuance Payments Of Debt Ann.	-	-	-304	7,350	-4,149	-12,433	-8,414	-2,683	26,247	3,229	-3	5,588	16,623
NetLongTermDebtIssuance_A Net Long Term Debt Issuance Ann.	-	-	-2,803	7,350	-4,149	-12,433	-8,414	-2,683	29,946	-72	-25	5,617	16,642
NetShortTermDebtIssuance_A Net ST Debt Issuance Ann.	-	-	2,499		-	-			-3,699	3,301	22	-29	-19
NetCommonStockIssuance_A Net Common Stock Issuance Ann.	-	-	-980	-1,708	-1,972	-1,487	-934	-978	-629	-12,014	-1,410	-6,033	-7,567
CommonStockIssuance_A Common Stock Issuance Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
CommonStockPayments_A Common Stock Payments Ann.	-	-	-980	-1,708	-1,972	-1,487	-934	-978	-629	-12,014	-1,410	-6,033	-7,567
dividend_1Y_actual Dividend 1year	5.6%	7%	6.6	6.2	5.9	5.6	5.2	4.7	4.3	3.6	2.6	2.3	2
DividendPerShare_A Dividend Per Share Ann.	5.5%	6.9%	6.7	6.3	6	5.7	5.3	4.8	4.4	4	2.6	2.4	2.1
NetOtherFinancingCharges_A Net Other Financing Charges Ann.	-	-	45	-42	-742	-1,102	-674	-333	-552	-104	-246	-34	-152
CashAndCashEquivalentEndOfYear_A Cash Plus Cash Eqv. End Of Year Ann.	-17.2%	-9.2%	5,229	5,524	12,814	9,201	9,746	8,449	39,924	7,289	9,303	5,100	8,399
NetIncDecInCashAndCashEquivalents_A Net Increase In Cash Plus Cash Eqv.s Ann.	-	-	-337	-7,225	3,608	-483	1,394	-31,470	32,628	-1,975	4,174	-2,961	351
CashAndCashEquivalentBeginOfYear_A Cash Plus Cash Eqv. Begin Of Year Ann.	-17.2%	-32.7%	5,524	12,814	9,201	9,746	8,449	39,924	7,289	9,303	5,100	8,399	8,348
IncomeTaxPaidSupplementalData_A Income Tax Paid Supplemental Data Ann.	6.7%	16.7%	3,626	4,064	4,702	2,988	3,648	1,674	1,447	-	1,696	3,563	1,108
InterestPaidSupplementalData_A Interest Paid Supplemental Data Ann.	5.6%	2.8%	3,002	2,811	2,469	2,546	2,712	2,619	1,794	1,215	1,099	986	536
CapitalExpenditure_A Capex Ann.	-	-	-1,214	-974	-777	-695	-787	-798	-552	-638	-529	-479	-532
IssuanceOfCapitalStock_A Issuance Of Capital Stock Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
IssuanceOfDebt_A Issuance Of Debt Ann.	66.9%	25.4%	9,291	21,971		2,000	1,000	3,000	31,482	9,264		11,627	20,660
RepaymentOfDebt_A Repayment Of Debt Ann.	-	-	-9,595	-14,621	-4,149	-14,433	-9,414	-5,683	-5,235	-6,035	-25	-6,010	-4,018
RepurchaseOfCapitalStock_A Repurchase Of Capital Stock Ann.	-	-	-980	-1,708	-1,972	-1,487	-934	-978	-629	-12,014	-1,410	-6,033	-7,567
FreeCashFlow_A Free Cash Flow Ann.	-9.8%	1.2%	17,816	17,832	22,062	24,248	21,990	16,790	12,772	12,789	9,431	6,562	7,003

*All financials are in USD Million and price data in USD

Add metric to table

Search...

Cash from Operating Act. Ann.

1Y CHG

1.2%

2Y CAGR

-8.7%

3Y CAGR

-8.6%

5Y CAGR

1.6%

7Y CAGR

5.1%

10Y CAGR

9.7%

Cash from Operating Activity Annual growth is stable compared to historical averages.

Forecaster
Quarterly
Competitors/Peers
Annual
Balance Sheet
Ratios
Cash Flow

New 52W High today

AbbVie quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

AbbVie - Forecaster

Forecaster Analyst Estimates for AbbVie share price target, revenues, EPS, net income and more

AbbVie - Earnings Report - Quarterly Results

AbbVie quarterly results: revenue, profit, and P&L – 13 quarter history

Quarterly Revenue AbbVie Jun-2026 Quarterly Revenue is $16,990 Million which is growth of 10.2% YoY.

Quarterly Net Profit AbbVie Jun-2026 Quarterly Net Profit is $3,613 Million which is growth of 285.2% YoY.

AbbVie - Competitors/Peers

AbbVie competitor comparison and performance snapshot within industry

AbbVie - Earnings Report - Annual Results

AbbVie annual results: revenue, profit, P&L, and margins as of Dec 2025 – 11 year history

Annual Revenue AbbVie Dec-2025 Annual Revenue is $61,160 Million which is growth of 8.6% YoY.

Annual Net Profit AbbVie Dec-2025 Annual Net Profit is $4,226 Million which is growth of -1.2% YoY.

AbbVie - Balance Sheet

AbbVie balance sheet as of Dec 2025: assets, liabilities, reserves, and borrowings – 11 year history

Total Shareholders Fund AbbVie Dec-2025 Total Shareholders Fund is $-3,270 Million which is growth of -198.3% YoY.

Total Assets AbbVie Dec-2025 Total Assets is $133,960 Million which is growth of -0.9% YoY.

AbbVie - Ratios

AbbVie ROE, ROCE, book value, and debt-to-equity ratio as of Dec 2025 – 11 year history

Book Value Per Share AbbVie Book Value Per Share is $-2 which is growth of -198.2% YoY.

ROE AbbVie ROE is 0% which is growth of 0% YoY.

AbbVie - Cash Flow

AbbVie cash flow: net, operating, investing, and financing flows as of Dec 2025 – 11 year history

Cash From Operating Activity AbbVie Dec-2025 Cash From Operating Activity is $19,030 Million which is growth of 1.2% YoY.

Net Cash Flow AbbVie Dec-2025 Net Cash Flow is $-337 Million which is growth of 95.3% YoY.